Allucent
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · North Carolina, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2000 Centre Green Way Ste 300, Cary, Nor...Phone Number
(919) 361-2286Website
www.allucent.comRevenue
$361.6 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
6
2
2
About Allucent
We are delighted to announce that our company name will be changing to Allucent. Purpose-built through the convergence of several leading providers, Allucent is a global provider of comprehensive drug development solutions across a variety of therapeutic areas with more than 30 years of experience and operations in over 60 countries. Our individualized partnership approach provides experience-driven insights and expertise to assist our clients in successfully navigating the complexities of delivering novel treatments to patients who need them.Explore more
Allucent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allucent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Allucent, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Allucent recently announced quarterly report
Product Launch: Get notified when Allucent launches new products
Check out if Allucent is spiking on competitors!
Check if Allucent has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Allucent has new funding data
Congratulate Masked Content for being promoted to Masked Content at Allucent
Click to see if Allucent had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Allucent
Find 2 more new buyers
Compare Similar Companies to Allucent
Compare insights from companies similar to Allucent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Allucent is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Allucent is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Allucent.
Allucent Tech Stack
A closer look at the technologies used by Allucent
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Allucent News & Media
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
Strategic Partnership with Global Clinical Research Organization (CRO) Signifies Advancement in Clinical Development of Lucid-21-302 (Lucid-MS), a Novel First-in-Class Treatment Inhibiting Demyelination Strategic Partnership with Global Clinical Research Organization (CRO) Signifies Advancement in Clinical Development of Lucid-21-302 (Lucid-MS), a Novel First-in-Class Treatment Inhibiting DemyelinationSilo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and AnxietySilo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected Allucent, a global full-service clinical research organization (CRO), to support the Company’s final preparations and planned submission of its investigational new drug application (IND) to the FDA for a Phase 1 clinical trial of its intranasal prophylactic SPC-15 asAllucent Expands Leadership Team with New COO, CCO, and CIO Appointments
Allucent, a global contract research organization (CRO) […]
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Allucent
Sign Up For FreeTo access detailed company insights
We are delighted to announce that our company name will be changing to Allucent. Purpose-built through the convergence of several leading providers, Allucent is a global provider of comprehensive drug development solutions across a variety of therapeutic areas with more than 30 years of experience and operations in over 60 countries. Our individual... Read More
